To enhance innovation in scientific research and pursue novel approaches to supporting patients with cancer, in
2015 Bristol-Myers Squibb France launched the Foundation for Immuno-Oncology Research. This organization funds
projects at French public research institutes in four areas of focus, including basic research,
clinical/translational research, public health/patient pathways and a special focus on pediatric cancer. The
grants we fund are helping to support patients across the spectrum of care.
www.fondation-bms.fr